The Effects of a Regenerative Mitochondrial Medication on Physiological Parameters in Case of Diabetes Mellitus Type II

Center for Integrative Medicine, Germany

Status and phase: Unknown; Phase 2

Conditions: Diabetes Mellitus, Type II

Treatments: Dietary Supplement: Infusion therapy; Device: Webermedical device; Behavioral: Nutritional therapy; Dietary Supplement: Mitochondrial preparations

Study type: Interventional

Funder types: Other

Identifiers

NCT01197092

CS-101-01

Details and patient eligibility

About

A treatment with the concept of mitochondrial medication developed by Dr Heinrich Kremer can demonstrably improve and successfully treat actual parameters of Diabetes Mellitus II as well as its risk factors.

Enrollment: 40 estimated patients

Sex: All

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• men and women between the ages of 18 and 60
• recently diagnosed Diabetes Type II (within the last 12 months)

Exclusion criteria

• no orally-taken medication up to present
• no insulin therapy
• no diseases resulting from diabetes like Nephropathy, Neuropathy, Angiopathy or Retinopathy
• fasting blood sugar values in the morning under 200mmol
• sufficient production of insulin

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

40 participants in 2 patient groups

Verum

Active Comparator group

Treatment:

Device: Webermedical device

Dietary Supplement: Mitochondrial preparations

Behavioral: Nutritional therapy

Dietary Supplement: Infusion therapy

Control

Experimental group

Treatment:

Behavioral: Nutritional therapy